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ment, we performed a screening of transcription factors using a promoter
assay of COL10A1 gene, and identiﬁed hypoxia-inducible factor 2α (HIF2A;
encoded by EPAS1) as the most potent transactivator. HIF2A enhanced
promoter activities of not only COL10A1, but also MMP13 and VEGF through
speciﬁc binding to the respective hypoxia-responsive elements. HIF2A,
independently of the oxygen-dependent hydroxylation, was essential for
endochondral ossiﬁcation of cultured chondrocytes and embryonic skeletal
growth in mice. HIF2A was induced in osteoarthritic cartilages of mice
and humans. The HIF2A heterozygous deﬁcient mice exhibited resistance
to OA development, and a functional SNP in the human HIF2A gene was
associated with knee OA in a Japanese population. Hence, HIF2A is an ex-
tensive transactivator during endochondral ossiﬁcation, and may represent
a therapeutic target for OA.
In addition to HIF2A, recent mouse genetic approaches by others and
us found that other endochondral ossiﬁcation signals like Runx2, C/EBPβ,
carminerin, osteoprotegerin, β-catenin, syndecan-4, hedgehog, etc. are in-
volved in the OA development. The proteinases produced during the
endochondral ossiﬁcation process are likely to cause cartilage degradation
at the center of the joint and osteophyte formation at the periphery.
The difference of the two sites may depend on the vascularity. At the
periphery, vascularity is accessible from the synovium or tendon, which
completes endochondral ossiﬁcation and forms osteophytes, just as it does
during skeletal growth and fracture healing. However, in the center, the
vascularity is not accessible from the edge, so that it may end up with
cartilage degradation without being replaced by bone. Molecules related
to the endochondral ossiﬁcation signals might become therapeutic targets
altering the course of this disabling disease.
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Purpose: Osteoarthritis (OA) is the leading cause of musculoskeletal dis-
ability with few conventional and surgical treatment options. Although
advanced imaging techniques are presently not applied in a clinical routine
setting for diagnostic purposes, rapid technical developments in mag-
netic resonance imaging (MRI) and application of image post-processing
methodology in combination with longitudinal studies applying MRI to
large cohorts have contributed greatly to disease understanding in recent
years. Focus of this presentation will be an overview of the role of MRI
A.) clinically including differential diagnosis and longitudinal monitoring of
disease on a patient level, B.) as a surrogate outcome measure for structural
endpoints in clinical studies, including efforts to isolate patients at greatest
risk for progression and C.) in understanding OA symptoms. In addition, the
current role of conventional radiography and other less commonly applied
methods will be re-discussed. As the vast majority of ongoing research in
OA imaging is focusing on the knee joint, the center of this overview will
also be the knee.
Methods: The radiographic examination of joints is still useful to establish
a diagnosis of OA and still holds an important role for deﬁning inclusion
criteria into clinical trials. Furthermore, radiographically detected joint
space narrowing is still the only accepted imaging outcome measure
in trials assessing disease modifying osteoarthritis drugs (DMOADs). The
current role of radiography will be discussed and advances in technology
of joint space width assessment will be presented.
The role of MRI has evolved rapidly over recent years. In the context
of joint imaging, cartilage imaging seems to be at the forefront of these
developments. Especially compositional MRI of cartilage ultrastructure has
lead to understanding of early, potentially reversible pathology. Advances
in quantitative morphologic cartilage assessment including novel ana-
lytic approaches have further added largely to understanding of disease
progression in recent years.
Due to MRI a change in paradigm has occurred in that it seems accepted
consensus now to perceive OA not as a disease of cartilage only but as
a whole-organ disorder involving multiple joint tissues leading eventually
to joint failure. Whole organ MRI assessment has contributed a lot to this
change in perception and will be discussed in detail. Many different joint
structures are of relevance in a clinical context and for disease progression.
Despite cartilage, most important seem to be the menisci, the subchondral
bone, ligamentous structures and the synovium. A consensus-based sugges-
tion for an MRI deﬁnition of early or pre-OA and deﬁnite OA is presented
in light of upcoming analyses of the large MRI datasets. Although MRI is
the most important methodology in imaging of OA and cartilage, other
modalities such as ultrasound, FDG-PET and computed tomography (CT)
do play a potentially important complimentary role that will be touched
brieﬂy.
Conclusions: The ﬁeld of imaging in OA and cartilage has evolved rapidly
and despite the continued lack of eﬃcient therapies there is hope that
especially imaging might be in a position to eventually drive therapeu-
tic break through. Publicly available OAI MRI data together with other
presently ongoing large epidemiological studies should allow the research
community to rapidly advance in understanding the natural course of the
disease and deﬁne risk factors relevant for OA disease progression. Current
data suggests that stratiﬁcation of risk is feasible to ascertain those at risk
for rapid progression using a number of different imaging-based metrics
including knee alignment, meniscal damage, bone marrow lesions, possibly
synovitis and joint effusion, and late stage disease. Identifying persons at
greatest risk for progression has important implications for clinical trial
planning and may possibly enhance study eﬃciency.
Eventually imaging and foremost MRI will be applied as surrogate measures
of disease progression, particularly in therapeutic intervention trials. Once
the clinical importance of these imaging endpoints is established, additional
advances in technology will drive a more comprehensive analysis of car-
tilage morphology, composition and other articular tissue pathology than
currently possible. This will be of particular importance once structure-
or disease-modifying interventions become available, as this will require
monitoring treatment response in large sets of OA patients. Only through
the availability of such interventions imaging will eventually play a relevant
and important role in clinical decision making and clinical practice.
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The menisci are two semi-circular ﬁbrocartilage structures positioned be-
tween the joint surfaces of the femur and tibia in the medial and lateral
knee joint compartments. Each meniscus covers approximately two-thirds
of the corresponding articular surface of the tibia. The menisci play a
critical protective role for the knee joint through shock absorption and load
distribution. When the knee is loaded, the tensile strength of the meniscal
matrix counteracts extrusion of the meniscus, and the meniscus distributes
stress over a large area of the articular cartilage; the healthy meniscus
mainly responds to load with compression. Loss of meniscal function by
meniscal tear or surgical removal of meniscal tissue has been strongly
associated with the development of radiographic knee osteoarthritis (OA).
Meniscal lesions have also been strongly linked to e.g. cartilage loss and
the development of subchondral bone marrow lesions which are both
prominent features of the disorder.
Meniscal lesions are regular ﬁndings on magnetic resonance imaging (MRI)
of the knee, especially in knees with OA typically in the form of horizontal,
ﬂap, and (or) complex tears, meniscal maceration, destruction or extru-
Figure 1. Prevalence of meniscal tear or maceration/destruction in the right knee among
991 middle-aged and elderly persons from the general population in Framingham, MA,
USA, according to age group and sex (all persons with previous knee surgery were ex-
cluded from the prevalence estimates of meniscal maceration/destruction) (Englund et
al. N Engl J Med. 2008 Sep 11;359[11]:1108-15).
